leisure time -WSS

leisure time

author：Wikipedia 2025-10-02 12:31:37 - browse：1998

Cambridge: AbbVie — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Medicare bonuses could stop drug shortages under Senate plan

WSS

A pediatrician calls for Congress to pass the child tax credit deal

Medicare drug price lawsuits could be good politics for Biden

DeepMind touts AlphaFold's new skills as protein folding AI models face off

The health care issue Democrats can’t solve: hospital reform

Coloradans with cystic fibrosis could lose access to Trikafta

Humans aren't the only ones with an imagination. Rats have it too

knowledge

leisure time

focus

In age of alternative facts, a scholarly course on calling out crap

Maisha Meds is a PBM, but don't call it that

Walensky prepares to leave CDC — and Congress — behind

Pumping milk in bathrooms at health conferences is common

George Santos makes 1st court appearance after pleading not guilty to 13 counts

A pediatrician calls for Congress to pass the child tax credit deal

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Dana Farber says 6 studies to be retracted and 31 corrected

The cancer drug shortage isn’t new — and neither are the solutions

Explaining an after

entertainment

Medicare proceeds with plan to claw back hospital funds

Medicare drug price lawsuits could be good politics for Biden

FDA endorses new sterilization method for medical devices

Life sciences investors close nearly $6 billion in new funds

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Maisha Meds is a PBM, but don't call it that

knowledge

knowledge

entertainment

hotspot